Yannic Danger

1.2k total citations
19 papers, 971 citations indexed

About

Yannic Danger is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yannic Danger has authored 19 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Yannic Danger's work include Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Yannic Danger is often cited by papers focused on Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Yannic Danger collaborates with scholars based in France, Canada and Mali. Yannic Danger's co-authors include Hugues Gascan, Sylvie Chevalier, Elisa Ravon, Emilie Vénéreau, Laurence Preisser, Jérôme Pène, Jean‐Pierre Molès, Hans Yssel, Soufiane Ghannam and Carl D. Richards and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Scientific Reports.

In The Last Decade

Yannic Danger

18 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yannic Danger France	8	487	266	165	131	126	19	971
Andrés Rojas United States	16	451 0.9×	508 1.9×	310 1.9×	50 0.4×	65 0.5×	24	1.3k
Cinzia Manuelli Italy	18	484 1.0×	242 0.9×	128 0.8×	43 0.3×	178 1.4×	30	1.2k
Niwa Ali United Kingdom	13	1.3k 2.6×	318 1.2×	398 2.4×	57 0.4×	85 0.7×	21	1.9k
Erich Bünemann Germany	6	593 1.2×	115 0.4×	218 1.3×	36 0.3×	98 0.8×	7	972
Raffi Manoukian United States	12	327 0.7×	260 1.0×	183 1.1×	42 0.3×	83 0.7×	16	726
Özge Uluçkan United States	17	252 0.5×	329 1.2×	284 1.7×	32 0.2×	79 0.6×	25	907
Elisa Montanari Switzerland	16	239 0.5×	149 0.6×	53 0.3×	78 0.6×	36 0.3×	25	907
Christina Philippeos United Kingdom	11	262 0.5×	289 1.1×	238 1.4×	121 0.9×	30 0.2×	17	970
James S. Rush United States	17	581 1.2×	377 1.4×	167 1.0×	61 0.5×	71 0.6×	26	1.3k
Udo Holtick Germany	25	631 1.3×	337 1.3×	728 4.4×	68 0.5×	50 0.4×	87	1.9k

Countries citing papers authored by Yannic Danger

Since Specialization

Citations

This map shows the geographic impact of Yannic Danger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannic Danger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannic Danger more than expected).

Fields of papers citing papers by Yannic Danger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yannic Danger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannic Danger. The network helps show where Yannic Danger may publish in the future.

Co-authorship network of co-authors of Yannic Danger

This figure shows the co-authorship network connecting the top 25 collaborators of Yannic Danger. A scholar is included among the top collaborators of Yannic Danger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yannic Danger. Yannic Danger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Tanguy, A, Stéphane Paul, Jérôme Moreaux, et al.. (2025). Editing B cells at the IGHA2 gene position provides alternative route to therapeutic IgA production. Mucosal Immunology. 18(5). 1027–1035.

Dréano, Stéphane, Christophe Sirac, Anne Galy, et al.. (2024). Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens. Scientific Reports. 14(1). 22432–22432. 3 indexed citations

Kurma, Keerthi, Brigitte Collet, Laure Debure, et al.. (2022). MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways. Cell Death and Disease. 13(10). 895–895. 6 indexed citations

Danger, Yannic, et al.. (2021). Immunotherapy perspectives in the new era of B-cell editing. Blood Advances. 5(6). 1770–1779. 7 indexed citations

Danger, Yannic, Régis Lavigne, Charles Pineau, et al.. (2020). Serine 165 phosphorylation of SHARPIN regulates the activation of NF-κB. iScience. 24(1). 101939–101939. 7 indexed citations

Bertrand, Gérald, et al.. (2019). A new platelet alloantigen (Efs^a, HPA‐35bw) on glycoprotein IIIa leading to neonatal alloimmune thrombocytopenia. Transfusion. 59(7). 2463–2464. 6 indexed citations

Bertrand, Gérald, et al.. (2018). A case of neonatal thrombocytopenia caused by maternal alloimmunization against a new platelet antigen (Bzh^a, HPA‐34bw) located on GPIIIa. Transfusion. 59(4). 1402–1403. 2 indexed citations

Chevalier, Sylvie, Yannic Danger, Muhammad Arshad, et al.. (2015). Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis. Journal of Molecular Medicine. 93(12). 1355–1367. 24 indexed citations

Chesnel, Franck, Jean‐Philippe Gagné, Antoine Couturier, et al.. (2015). The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform. British Journal of Cancer. 113(2). 336–344. 16 indexed citations

10.

Danger, Yannic, et al.. (2015). Characterization of a new human monoclonal antibody directed against the Vel antigen. Vox Sanguinis. 110(2). 172–178. 7 indexed citations

11.

Arshad, Muhammad, Pierre Guihard, Yannic Danger, et al.. (2015). Oncostatin M induces IL-33 expression in liver endothelial cells in mice and expands ST2⁺CD4⁺lymphocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 309(7). G542–G553. 10 indexed citations

12.

Danger, Yannic, Bénédicte Brounais, Emmanuelle David, et al.. (2012). Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on Oncostatin M signaling. Bone. 50. S67–S67. 6 indexed citations

13.

Guihard, Pierre, Yannic Danger, Bénédicte Brounais, et al.. (2012). Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling. Stem Cells. 30(4). 762–772. 393 indexed citations

14.

Vénéreau, Emilie, Caroline Diveu, Linda Grimaud, et al.. (2010). Definition and Characterization of an Inhibitor for Interleukin-31. Journal of Biological Chemistry. 285(20). 14955–14963. 20 indexed citations

15.

Saux, Sabine Le, François Rousseau, Elisa Ravon, et al.. (2009). Molecular Dissection of Human Interleukin-31-mediated Signal Transduction through Site-directed Mutagenesis. Journal of Biological Chemistry. 285(5). 3470–3477. 17 indexed citations

16.

Pène, Jérôme, Sylvie Chevalier, Laurence Preisser, et al.. (2008). Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes. The Journal of Immunology. 180(11). 7423–7430. 429 indexed citations

17.

Danger, Yannic, P. Sandouk, Jean‐Michel Scherrmann, et al.. (2006). Design of cocaethylene and cocaine conjugates to produce highly selective polyclonal antibodies.. PubMed. 2(1). 53–8. 2 indexed citations

18.

Danger, Yannic, et al.. (2005). Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues. Journal of Immunological Methods. 309(1-2). 1–10. 10 indexed citations

19.

Danger, Yannic, et al.. (2004). Development of Monoclonal Antibodies Directed Against Cocaine and Cocaethylene: Potential New Tools for Immunotherapy. 23(4). 212–218. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact